PepGen Inc. financial data

Symbol
PEPG on Nasdaq
Industry
Pharmaceutical Preparations
Location
1 Marina Park Drive, Suite 900, Boston, MA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 819 % -20%
Debt-to-equity 24.6 % +35.2%
Return On Equity -62.7 % -54.8%
Return On Assets -50.4 % -46.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.6M shares +36.9%
Common Stock, Shares, Outstanding 23.8M shares +0.46%
Entity Public Float 97.7M USD
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 32.5M shares +36.5%
Weighted Average Number of Shares Outstanding, Diluted 32.5M shares +36.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 76.6M USD +26.8%
General and Administrative Expense 19.2M USD +23.5%
Operating Income (Loss) -95.8M USD -26.2%
Nonoperating Income (Expense) 6.75M USD +15.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -89.1M USD -27.1%
Net Income (Loss) Attributable to Parent -89.1M USD -28.5%
Earnings Per Share, Basic -3.29 USD/shares -123%
Earnings Per Share, Diluted -3.29 USD/shares -123%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 66.1M USD -55.1%
Marketable Securities, Current 95.2M USD
Cash, Cash Equivalents, and Short-term Investments 161M USD
Assets, Current 165M USD +9.58%
Property, Plant and Equipment, Net 4.24M USD -19.3%
Operating Lease, Right-of-Use Asset 22.5M USD -8.94%
Other Assets, Noncurrent 1.96M USD +14.9%
Assets 194M USD +6.28%
Accounts Payable, Current 7.74M USD +327%
Employee-related Liabilities, Current 2.07M USD +80%
Accrued Liabilities, Current 11.3M USD -2.68%
Liabilities, Current 22.1M USD +30.5%
Operating Lease, Liability, Noncurrent 16.4M USD -8.41%
Liabilities 38.5M USD +10.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -75K USD -677%
Retained Earnings (Accumulated Deficit) -228M USD -64.3%
Stockholders' Equity Attributable to Parent 155M USD +5.27%
Liabilities and Equity 194M USD +6.28%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.5M USD -46.1%
Net Cash Provided by (Used in) Financing Activities 87M USD +66798%
Net Cash Provided by (Used in) Investing Activities -11.3M USD -856%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 23.8M shares +0.46%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 53.1M USD
Deferred Tax Assets, Valuation Allowance 50.2M USD +133%
Deferred Tax Assets, Gross 58.1M USD +109%
Operating Lease, Liability 20.1M USD -17.9%
Depreciation 376K USD +151%
Payments to Acquire Property, Plant, and Equipment 53K USD -95.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -89.2M USD -28.8%
Lessee, Operating Lease, Liability, to be Paid 28M USD -17.3%
Property, Plant and Equipment, Gross 6.55M USD +6.94%
Operating Lease, Liability, Current 3.05M USD -12.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.09M USD +2.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 3M USD -52.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.92M USD -15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.19M USD +2.02%
Deferred Tax Assets, Operating Loss Carryforwards 8.04M USD +1596%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 700K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.28M USD +1.99%
Depreciation, Depletion and Amortization 1.5M USD +87.5%
Deferred Tax Assets, Net of Valuation Allowance 50.2M USD +133%
Share-based Payment Arrangement, Expense 8.75M USD +48.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%